TENASCIN-C EXPRESSION IN ENDOMETRIOSIS

被引:0
作者
Ulukus, Murat [1 ]
Ulukus, E. Cagnur [2 ]
Goker, Ege N. Tavmergen [3 ]
Zekioglu, Osman [4 ]
Gundem, Gursen [1 ]
Ulukus, Mustafa [1 ]
Tavmergen, Erol [3 ]
机构
[1] Ege Univ, Fac Med, Dept Obstet & Gynecol, Izmir, Turkey
[2] 9 Eylul Univ, Fac Med, Dept Pathol, Izmir, Turkey
[3] Ege Univ, Family Planning Infertil Res & Treatment Ctr, TR-35100 Izmir, Turkey
[4] Ege Univ, Fac Med, Dept Pathol, Izmir, Turkey
关键词
endometriosis; eutopic endometrium; tenascin-C;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate the expression of Tenascin-C (TN-C) in endometrium and endometriosis. Study Design: Comparative immunohistochemical study. Setting: Academic medical center. Patients: Ectopic (n = 32) and homologous eutopic endometrium (n = 20) from women with endometriosis and endometrium from women without endometriosis (n = 17) were included in the study. Interventions: Tissue sections were immunostained with monoclonal TN-C antibody. Main outcome measures: Microscopic evaluation to assess the presence and localization of TN-C throughout the menstrual cyle in both eutopic and ectopic endometrial tissues of women with endometriosis and compare it to the normal endometrium. Results: No statistical difference of TN-C expression was found neither between both groups of endometrial samples and nor between the eutopic and ectopic endometrial samples of women with endometriosis. Conclusions: Expression of TN-C seems to be restricted in both normal endometrial tissues and endometrial tissues of women with endometriosis. Our findings are partially controversial with the studies suggesting that this ECM glycoprotein have a regenerative role on the endometrium. However, it seems to have a role on the implantation process and it may be related with the infertility mechanisms involved in endometriotic disease.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 24 条
[11]   TENASCIN IN NORMAL, REACTIVE, HYPERPLASTIC, AND NEOPLASTIC TISSUES - BIOLOGIC AND PATHOLOGICAL IMPLICATIONS [J].
KOUKOULIS, GK ;
GOULD, VE ;
BHATTACHARYYA, A ;
GOULD, JE ;
HOWEEDY, AA ;
VIRTANEN, I .
HUMAN PATHOLOGY, 1991, 22 (07) :636-643
[12]  
KOUKOULIS GK, 1993, J SUBMICR CYTOL PATH, V25, P285
[13]   ABERRANT INTEGRIN EXPRESSION IN THE ENDOMETRIUM OF WOMEN WITH ENDOMETRIOSIS [J].
LESSEY, BA ;
CASTELBAUM, AJ ;
SAWIN, SW ;
BUCK, CA ;
SCHINNAR, R ;
BILKER, W ;
STROM, BL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) :643-649
[14]   Medical management of endometriosis and infertility [J].
Lessey, BA .
FERTILITY AND STERILITY, 2000, 73 (06) :1089-1096
[15]   Endometriosis and assisted reproductive technologies: are outcomes affected? [J].
Mahutte, NG ;
Arici, A .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2001, 13 (03) :275-279
[16]   The relevance of the peritoneal fluid in endometriosis-associated infertility [J].
Mulayim, N ;
Arici, A .
HUMAN REPRODUCTION, 1999, 14 :67-76
[17]   DATING THE ENDOMETRIAL BIOPSY [J].
NOYES, RW ;
HERTIG, AT ;
ROCK, J .
FERTILITY AND STERILITY, 1950, 1 (01) :3-25
[18]   Expression of tenascin in human cervical cancer -: Association of tenascin expression with clinicopathological parameters [J].
Pilch, H ;
Schäffer, U ;
Schlenger, K ;
Lautz, A ;
Tanner, B ;
Höckel, M ;
Knapstein, PG .
GYNECOLOGIC ONCOLOGY, 1999, 73 (03) :415-421
[19]   Was Sampson wrong? [J].
Redwine, DB .
FERTILITY AND STERILITY, 2002, 78 (04) :686-693
[20]  
SASANO H, 1993, MODERN PATHOL, V6, P323